These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 1011296)

  • 1. Administration of aspartame in non-insulin-dependent diabetics.
    Stern SB; Bleicher SJ; Flores A; Gombos G; Recitas D; Shu J
    J Toxicol Environ Health; 1976 Nov; 2(2):429-39. PubMed ID: 1011296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of aspartame in phenylketonuric heteroxygous adults.
    Koch R; Shaw KN; Williamson M; Haber M
    J Toxicol Environ Health; 1976 Nov; 2(2):453-7. PubMed ID: 796477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose tolerance, blood lipid, insulin and glucagon concentration after single or continuous administration of aspartame in diabetics.
    Okuno G; Kawakami F; Tako H; Kashihara T; Shibamoto S; Yamazaki T; Yamamoto K; Saeki M
    Diabetes Res Clin Pract; 1986 Apr; 2(1):23-7. PubMed ID: 3522147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of aspartame by apparently healthy children and adolescents.
    Frey GH
    J Toxicol Environ Health; 1976 Nov; 2(2):401-15. PubMed ID: 137987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of aspartame in young persons during weight reduction.
    Knopp RH; Brandt K; Arky RA
    J Toxicol Environ Health; 1976 Nov; 2(2):417-28. PubMed ID: 796476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of aspartame on diabetic rats and diabetic patients.
    Shigeta H; Yoshida T; Nakai M; Mori H; Kano Y; Nishioka H; Kajiyama S; Kitagawa Y; Kanatsuna T; Kondo M
    J Nutr Sci Vitaminol (Tokyo); 1985 Oct; 31(5):533-40. PubMed ID: 3908628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of aspartame on plasma amino acid profiles of diabetic patients with chronic renal failure.
    Gupta V; Cochran C; Parker TF; Long DL; Ashby J; Gorman MA; Liepa GU
    Am J Clin Nutr; 1989 Jun; 49(6):1302-6. PubMed ID: 2729170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of loading doses of aspartame by two phenylketonuric (PKU) children compared with two normal children.
    Koch R; Schaeffler G; Shaw NF
    J Toxicol Environ Health; 1976 Nov; 2(2):459-69. PubMed ID: 1011297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspartame use by persons with diabetes.
    Nehrling JK; Kobe P; McLane MP; Olson RE; Kamath S; Horwitz DL
    Diabetes Care; 1985; 8(5):415-7. PubMed ID: 3902420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic effects of adding sucrose and aspartame to the diet of subjects with noninsulin-dependent diabetes mellitus.
    Colagiuri S; Miller JJ; Edwards RA
    Am J Clin Nutr; 1989 Sep; 50(3):474-8. PubMed ID: 2672774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological properties of aspartame. I. Evaluation of central nervous system effects.
    Potts WJ; Bloss JL; Nutting EF
    J Environ Pathol Toxicol; 1980; 3(5-6):341-53. PubMed ID: 7441089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neuropsychiatric effects of aspartame in normal volunteers.
    Lapierre KA; Greenblatt DJ; Goddard JE; Harmatz JS; Shader RI
    J Clin Pharmacol; 1990 May; 30(5):454-60. PubMed ID: 2347957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circadian variations in plasma immunoreactive insulin (IRI) and C-peptide concentrations in adult onset (type II) diabetes mellitus.
    Nicolau GY; Haus E; Lakatua DJ; Bogdan C; Petrescu E; Sackett-Lundeen L; Stelea S; Stelea P
    Endocrinologie; 1984; 22(1):3-16. PubMed ID: 6369501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood glucose profiles in insulin-dependent Zambian diabetics.
    Mulaisho C
    Med J Zambia; 1979; 13(5):85-9. PubMed ID: 122431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of oral aspartame on plasma phenylalanine in humans and experimental rodents. Short note.
    Wurtman RJ; Maher TJ
    J Neural Transm; 1987; 70(1-2):169-73. PubMed ID: 3668518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can aspartame meet our expectations?
    Horwitz DL; Bauer-Nehrling JK
    J Am Diet Assoc; 1983 Aug; 83(2):142-6. PubMed ID: 6348131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to single dose of aspartame or saccharin by NIDDM patients.
    Horwitz DL; McLane M; Kobe P
    Diabetes Care; 1988 Mar; 11(3):230-4. PubMed ID: 3046854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspartame, behavior, and cognitive function in children with attention deficit disorder.
    Shaywitz BA; Sullivan CM; Anderson GM; Gillespie SM; Sullivan B; Shaywitz SE
    Pediatrics; 1994 Jan; 93(1):70-5. PubMed ID: 7505423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The biological properties of aspartame. V. Effects on a variety of physiological parameters related to inflammation and metabolism.
    Aspinall RL; Saunders RN; Pautsch WF; Nutting EF
    J Environ Pathol Toxicol; 1980; 3(5-6):387-95. PubMed ID: 6108346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspartame metabolism in normal adults, phenylketonuric heterozygotes, and diabetic subjects.
    Filer LJ; Stegink LD
    Diabetes Care; 1989 Jan; 12(1):67-74. PubMed ID: 2653751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.